Abbott’s Alere resolves U.S. diagnostic device probe for $33.2 million
BOSTON (Reuters) – Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories…